Transplantation-associated thrombotic microangiopathy (TA-TMA) is a challenging
diagnosis after hematopoietic stem cell transplantation. Although endothelial injury …

Lung transplantation has evolved into a life-saving treatment with improved quality of life for
patients with end-stage respiratory failure unresponsive to other medical or surgical …

Transplant-associated thrombotic microangiopathy (TMA) leads to generalized endothelial
dysfunction that can progress to multiorgan injury, and severe cases are associated with …

Calcineurin inhibitor (CNI) nephrotoxicity was recognized in Cambridge in the late 1970s.
The vasoconstrictor impact of cyclosporine (CsA) and to a lesser extent tacrolimus, in both …

Background While BK polyoma virus nephropathy (PVN) is a well-recognized cause of renal
allograft dysfunction, PVN of native kidneys is likely under-recognized. Methods We present …

Hematopoietic stem cell transplant (HSCT) patients are at risk for acute kidney disease and
CKD, which confer excess morbidity and mortality in this patient population. A main cause of …

In recent years, there has been an increasing number of clinical trials for the treatment of
nonalcoholic steatohepatitis (NASH). People living with human immunodeficiency virus …

Lung transplant (LTx) physicians are responsible for highly complex post-LTx care, including
monitoring of kidney function and responding to kidney function loss. Better survival of the …

Hematopoietic stem cell transplantation (HSCT) exposes a patient's kidneys to a unique
combination of challenges, including high-dose radiation, anemia, chemotherapeutic …

After transplantation of nonrenal solid organs, an acute decline in kidney function develops
in the majority of patients. In addition, a significant number of nonrenal solid organ transplant …